Depression affects more than 280 million people worldwide, and approximately one-third of patients with major depressive disorder fail to respond to conventional antidepressants. The search for more ...

Rapid-acting antidepressants, including ketamine, scopolamine and psilocybin, have been found to have immediate and lasting positive effects on mood in patients with major depressive disorder but how ...

Dipa Kamdar does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their ...

Q. I read recently in your column about an amnesia reaction to scopolamine. I would like to share my husband’s scopolamine story. When he has had surgery in the past, the doctors have applied a ...

Q: I read recently in your column about an amnesia reaction to scopolamine. I would like to share my husband’s scopolamine story. When he has had surgery in the past, the doctors have applied a ...

The Company is scheduling a meeting with the FDA to discuss the issues raised in the letter. The Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) to Defender ...